Provider Alert! Synagis Season Extended for Counties in Southeast Texas and Gulf Coast Areas
Date: February 26, 2021 Attention: All Providers Providers should monitor the Texas Children’s Health Plan (TCHP) Provider Portal regularly for alerts and updates associated to the COVID-19 event. TCHP reserves the right to update and/or change this information without prior notice due to the evolving nature of the COVID-19 event. Call to action: Synagis (palivizumab) is indicated for children with a high risk of infection to respiratory syncytial virus (RSV). This virus causes respiratory tract infections and severe lung disease in infants and...
